Chengli Liu Selected Research

Chengli Liu Research Topics

Disease

7	Neoplasms (Cancer) 05/2024 - 06/2014
5	Pancreatic Neoplasms (Pancreatic Cancer) 04/2015 - 06/2014
4	Neuroinflammatory Diseases 03/2024 - 04/2022
4	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 03/2024 - 11/2022
4	Inflammation (Inflammations) 12/2023 - 01/2020
3	Brain Injuries (Brain Injury) 03/2024 - 11/2022
3	Ischemic Stroke 09/2023 - 04/2022
2	Stroke (Strokes) 05/2024 - 11/2022
2	Wounds and Injuries (Trauma) 03/2024 - 01/2021
2	Central Nervous System Diseases (CNS Diseases) 12/2023 - 12/2023
2	Brain Edema (Cerebral Edema) 12/2023 - 11/2022
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 02/2023 - 06/2022
2	Carcinogenesis 11/2021 - 03/2015
1	Urinary Bladder Neoplasms (Bladder Cancer) 05/2024
1	Circulating Neoplastic Cells 05/2024
1	Iron Overload 05/2024
1	Bacterial Infections (Bacterial Infection) 01/2024
1	Pulmonary Edema 12/2023
1	Ischemia 09/2023
1	Infarction (Infarctions) 02/2023
1	Infections 09/2022
1	Jaundice (Icterus) 09/2022
1	Obstructive Jaundice (Cholestatic Jaundice) 09/2022
1	Heartburn (Pyrosis) 01/2020
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2020
1	Chest Pain (Chest Pains) 01/2020
1	Gastroesophageal Reflux (GERD) 01/2020
1	Neoplasm Metastasis (Metastasis) 03/2015
1	Adenocarcinoma 03/2015
1	Carcinoma (Carcinomatosis) 01/2015
1	Cleft Lip (Harelip) 06/2014
1	Leiomyosarcoma 04/2010

Drug/Important Bio-Agent (IBA)

3	IronIBA 05/2024 - 11/2022
3	Glucose (Dextrose)FDA LinkGeneric 09/2023 - 06/2022
3	CateninsIBA 01/2023 - 06/2022
2	Proteins (Proteins, Gene)FDA Link 05/2024 - 03/2015
2	InflammasomesIBA 03/2024 - 12/2023
2	Oxygen (Dioxygen)IBA 09/2023 - 06/2022
2	Taurine FDA Link 01/2023 - 11/2022
2	RNA (Ribonucleic Acid)IBA 10/2022 - 11/2021
2	Tissue Plasminogen Activator (Alteplase)FDA Link 06/2022 - 04/2022
2	Small Interfering RNA (siRNA)IBA 04/2015 - 06/2014
1	AntigensIBA 05/2024
1	PolymersIBA 05/2024
1	nuclear matrix protein 22IBA 05/2024
1	Hemoglobins (Hemoglobin)IBA 05/2024
1	FibrinIBA 03/2024
1	HydrogelsIBA 03/2024
1	graphene oxideIBA 01/2024
1	TitaniumIBA 01/2024
1	Phosphotransferases (Kinase)IBA 12/2023
1	CXC ChemokinesIBA 12/2023
1	CC ChemokinesIBA 12/2023
1	Hematoxylin (Haematoxylon)IBA 12/2023
1	ibrutinibIBA 12/2023
1	Eosine Yellowish-(YS) (Eosin)IBA 12/2023
1	Agammaglobulinaemia Tyrosine KinaseIBA 12/2023
1	AntioxidantsIBA 09/2023
1	Codon (Codons)IBA 12/2022
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 12/2022
1	Neuroprotective AgentsIBA 11/2022
1	Small Cytoplasmic RNAIBA 10/2022
1	Exenatide (Byetta)FDA Link 06/2022
1	Glucagon-Like Peptide-1 ReceptorIBA 06/2022
1	Matrix Metalloproteinases (MMPs)IBA 04/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2022
1	3' Untranslated Regions (3' UTR)IBA 11/2021
1	ElementsIBA 11/2021
1	MicroRNAs (MicroRNA)IBA 11/2021
1	Hormones (Hormone)IBA 01/2020
1	AcidsIBA 01/2020
1	zuojinIBA 01/2020
1	PowdersIBA 01/2020
1	Erythropoietin FDA Link 01/2020
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 03/2015
1	Messenger RNA (mRNA)IBA 03/2015
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 03/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2015
1	8-hydroxyguanineIBA 07/2014
1	DNA Glycosylases (DNA Glycosylase)IBA 07/2014
1	Biomarkers (Surrogate Marker)IBA 07/2014
1	Telomerase (Telomerase Reverse Transcriptase)IBA 06/2014
1	Cadherins (E-Cadherin)IBA 06/2014
1	EphA4 ReceptorIBA 06/2014
1	Eph Family Receptors (Eph Receptors)IBA 06/2014

Therapy/Procedure

4	Therapeutics 03/2024 - 01/2015
1	Stents 09/2022
1	Length of Stay 09/2022
1	Tracheotomy 01/2021
1	Pancreatectomy 01/2015
1	Drug Therapy (Chemotherapy) 04/2010